Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Total-Cashflows-From-Investing-Activities" stands at -96.63 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Kyowa Kirin Co Ltd's second quarter result of -20.89 Billion JPY for the item "Total Cashflows From Investing Activities" represents a decrease of -50.88 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of -20.89 Billion JPY for the item "Total Cashflows From Investing Activities" represents an increase of 30.78 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of -96.63 Billion JPY for the item "Total Cashflows From Investing Activities" represents an increase of 8.77 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -9.70 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -9.70 Billion Japanese Yens.
The 3 year change is -80.29 Billion Japanese Yens.
The 5 year change is -301.57 Billion Japanese Yens.
The 10 year change is -113.43 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Cashflows From Investing Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Cashflows From Investing Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Cashflows From Investing Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Cashflows From Investing Activities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Cashflows From Investing Activities | 280,205,508,085.11 |